【结 构 式】 |
【药物名称】Ranolazine, CVT-303, KEG-1295, RS-43285(diHCl), Ranexa 【化学名称】1-[3-(2-Methoxyphenoxy)-2-hydroxypropyl]-4-[(2,6-dimethylphenyl)aminocarbonylmethyl]piperazine 【CA登记号】95635-55-5, 95635-56-6 (diHCl) 【 分 子 式 】C24H33N3O4 【 分 子 量 】427.54831 |
【开发单位】Roche Bioscience (Originator), CV Therapeutics (Licensee), Kissei (Licensee), Innovex (Comarketer) 【药理作用】Angina pectoris, Treatment of, Antiarrhythmic Drugs, CARDIOVASCULAR DRUGS, Heart Failure Therapy, Peripheral Vascular Disease, Treatment of, Treatment of Disorders of the Coronary Arteries and Atherosclerosis, Partial Fatty Acid Oxidation (pFOX) Inhibitors |
合成路线1
【1】 Deshpande PB, Chauhan AJ. 2006. Crystalline and amorphous form of ranolazine and the process for manufacturing them. WO 2006008753 |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 10355 | Diethylenediamine; Piperazine | 110-85-0 | C4H10N2 | 详情 | 详情 |
(II) | 24103 | 2-[(2-methoxyphenoxy)methyl]oxirane | C10H12O3 | 详情 | 详情 | |
(III) | 24109 | 1-(2-methoxyphenoxy)-3-(1-piperazinyl)-2-propanol | C14H22N2O3 | 详情 | 详情 | |
(IV) | 24100 | 2-chloro-N-(2,6-dimethylphenyl)acetamide | 2198-53-0 | C10H12ClNO | 详情 | 详情 |
合成路线2
【1】 Li SC, Huang HQ, Li ZJ. 2003. Synthesis of a novel antianginal agent Ranolazine. 中国药物化学杂志,13: 283~285 |
【2】 Lu WC, Li YQ, Zhao XG, et aL. 2004. Synthesis of ranolazine中国医药工业杂志,35: 641~642 |
【3】 Wang LS, Feng XY, Zhu HY. 2003. Synthesis of anti-angina drug ranolazine. 广西大学学报,自然科学版,28: 301~303 |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 13182 | Guaiacol; 2-Methoxyphenol | 90-05-1 | C7H8O2 | 详情 | 详情 |
(II) | 10146 | Epichlorohydrin; 2-(Chloromethyl)oxirane | 106-89-8 | C3H5ClO | 详情 | 详情 |
(III) | 24103 | 2-[(2-methoxyphenoxy)methyl]oxirane | C10H12O3 | 详情 | 详情 | |
(IV) | 17527 | 2,6-Xylidine; 2,6-Dimethylaniline; 2,6-Dimethylphenylamine | 87-62-7 | C8H11N | 详情 | 详情 |
(V) | 24100 | 2-chloro-N-(2,6-dimethylphenyl)acetamide | 2198-53-0 | C10H12ClNO | 详情 | 详情 |
(VI) | 24102 | N-(2,6-dimethylphenyl)-2-(1-piperazinyl)acetamide | C14H21N3O | 详情 | 详情 |
合成路线3
【1】 Yan J.2007. Synthesis of ranolazine.中国专利申请公开说明书.CN 1915982 |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 17527 | 2,6-Xylidine; 2,6-Dimethylaniline; 2,6-Dimethylphenylamine | 87-62-7 | C8H11N | 详情 | 详情 |
(II) | 24100 | 2-chloro-N-(2,6-dimethylphenyl)acetamide | 2198-53-0 | C10H12ClNO | 详情 | 详情 |
(III) | 24102 | N-(2,6-dimethylphenyl)-2-(1-piperazinyl)acetamide | C14H21N3O | 详情 | 详情 | |
(IV) | 10146 | Epichlorohydrin; 2-(Chloromethyl)oxirane | 106-89-8 | C3H5ClO | 详情 | 详情 |
(V) | 13182 | Guaiacol; 2-Methoxyphenol | 90-05-1 | C7H8O2 | 详情 | 详情 |
(VI) | 24103 | 2-[(2-methoxyphenoxy)methyl]oxirane | C10H12O3 | 详情 | 详情 |
合成路线4
【1】 Moen AR, Karstad R.Antfiansen T. 2005. Chemo-enzymatic synthesis of both enantiomers of the anti-anginal drug ranolazine. Biocat Biotransfonn, 23: 45~51 |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 10146 | Epichlorohydrin; 2-(Chloromethyl)oxirane | 106-89-8 | C3H5ClO | 详情 | 详情 |
(II) | 13182 | Guaiacol; 2-Methoxyphenol | 90-05-1 | C7H8O2 | 详情 | 详情 |
(III) | 24103 | 2-[(2-methoxyphenoxy)methyl]oxirane | C10H12O3 | 详情 | 详情 | |
(IV) | 66620 | 1-chloro-3-(2-methoxyphenoxy)propan-2-ol | C10H13ClO3 | 详情 | 详情 | |
(V) | 66621 | 1-chloro-3-(2-methoxyphenoxy)propan-2-yl butyrate | C14H19ClO4 | 详情 | 详情 | |
(VI) | 66622 | (R)-1-chloro-3-(2-methoxyphenoxy)propan-2-yl butyrate | C14H19ClO4 | 详情 | 详情 | |
(VII) | 66623 | (R)-1-chloro-3-(2-methoxyphenoxy)propan-2-ol | C10H13ClO3 | 详情 | 详情 | |
(VIII) | 24102 | N-(2,6-dimethylphenyl)-2-(1-piperazinyl)acetamide | C14H21N3O | 详情 | 详情 |
合成路线5
1) The acylation of 2,6-dimethylaniline (II) with chloroacetyl chloride by means of triethylamine in dichloromethane gives N-(2,6-dimethylphenyl) chloroacetamide (III), which is condensed with piperidine (IV) in refluxing ethanol to yield N-(2,6-dimethylphenyl)-2-piperazinoacetamide IV). Finally, this compound is condensed with 3-(2-methoxyphenoxy)-12-epoxypropane (VI) in refluxing methanol toluene.
【1】 Ainsworth, A.T.; Smith, D.G. (SmithKline Beecham plc); Ethanamine derivs., their preparation and use in pharmaceutical compsns. EP 0023385 . |
【2】 Prous, J.; Castaner, J.; RANOLAZINE < Rec INN; USAN >. Drugs Fut 1988, 13, 9, 837. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 11296 | 2-Chloroacetyl chloride; Chloroacetic chloride | 79-04-9 | C2H2Cl2O | 详情 | 详情 |
(II) | 17527 | 2,6-Xylidine; 2,6-Dimethylaniline; 2,6-Dimethylphenylamine | 87-62-7 | C8H11N | 详情 | 详情 |
(III) | 24100 | 2-chloro-N-(2,6-dimethylphenyl)acetamide | 2198-53-0 | C10H12ClNO | 详情 | 详情 |
(IV) | 10355 | Diethylenediamine; Piperazine | 110-85-0 | C4H10N2 | 详情 | 详情 |
(V) | 24102 | N-(2,6-dimethylphenyl)-2-(1-piperazinyl)acetamide | C14H21N3O | 详情 | 详情 | |
(VI) | 24103 | 2-[(2-methoxyphenoxy)methyl]oxirane | C10H12O3 | 详情 | 详情 |
合成路线6
2) The condensation of epoxide (VI) with piperazine (IV) in refluxing isopropanol gives 1-[3-(2-methoxyphenoxy)-2-hydroxypropyl]piperazine (VII), which is then condensed with chloroacetamide (III) in refluxing ethanol.
【1】 Ainsworth, A.T.; Smith, D.G. (SmithKline Beecham plc); Ethanamine derivs., their preparation and use in pharmaceutical compsns. EP 0023385 . |
【2】 Prous, J.; Castaner, J.; RANOLAZINE < Rec INN; USAN >. Drugs Fut 1988, 13, 9, 837. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 11296 | 2-Chloroacetyl chloride; Chloroacetic chloride | 79-04-9 | C2H2Cl2O | 详情 | 详情 |
(II) | 17527 | 2,6-Xylidine; 2,6-Dimethylaniline; 2,6-Dimethylphenylamine | 87-62-7 | C8H11N | 详情 | 详情 |
(III) | 24100 | 2-chloro-N-(2,6-dimethylphenyl)acetamide | 2198-53-0 | C10H12ClNO | 详情 | 详情 |
(IV) | 10355 | Diethylenediamine; Piperazine | 110-85-0 | C4H10N2 | 详情 | 详情 |
(VI) | 24103 | 2-[(2-methoxyphenoxy)methyl]oxirane | C10H12O3 | 详情 | 详情 | |
(VII) | 24109 | 1-(2-methoxyphenoxy)-3-(1-piperazinyl)-2-propanol | C14H22N2O3 | 详情 | 详情 |